Update of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological and substance use disorders, 2015

Resumen de los autores

This updated WHO mhGAP guideline provides evidence-based recommendations to support the management of priority mental, neurological and substance use (MNS) disorders by non-specialist health-care providers, particularly in low- and middle-income countries. Developed to maintain the validity of the 2010 mhGAP guideline in light of emerging evidence and implementation experience, it supports the scale-up of services for depression, psychosis, epilepsy, mental disorders with childhood onset, dementia, alcohol and drug use disorders, and self-harm and suicide, while contributing to implementation of the WHO Comprehensive Mental Health Action Plan 2013–2020. The guideline is intended primarily for front-line non-specialist health workers, as well as programme managers and specialists involved in training and supervision. The update was developed in accordance with the WHO Handbook for Guideline Development using systematic evidence reviews, the GRADE approach and structured consideration of benefits, harms, feasibility, values and preferences. It presents updated and new recommendations on pharmacological, psychological and psychosocial interventions, emphasizing context-appropriate, person-centred care delivered in non-specialist settings. The document also summarizes the methodology used to formulate recommendations and provides the evidence base supporting each recommendation, facilitating consistent implementation and future updates of the mhGAP programme.

Áreas y palabras clave

Cómo citar (APA 7)

World Health Organization (2015). Update of the Mental Health Gap Action Programme (mhGAP) guidelines for mental, neurological and substance use disorders, 2015. World Health Organization. https://iris.who.int/handle/10665/204132